| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ENTA | Common Stock | Award | $0 | +21K | +53.7% | $0.00 | 60.1K | Nov 23, 2022 | Direct | F1 |
| holding | ENTA | Common Stock | 28.1K | Nov 23, 2022 | By grantor retained annuity trust | F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ENTA | Stock Option (right to buy) | Award | $0 | +45K | $0.00 | 45K | Nov 23, 2022 | Common Stock | 45K | $45.00 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | Represents a grant of restricted stock units ("RSUs") under the Enanta Pharmaceuticals, Inc. ("Enanta") 2019 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Enanta common stock. The RSUs will vest and settle with respect to 25% of the award on December 4, 2023 and in substantially equal annual installments over the next three anniversaries thereafter. |
| F2 | These shares are held by grantor retained annuity trusts created by the reporting person for the benefit of himself and his two adult children. Since February 2022, the reporting person's holdings in these trusts have increased by a net 7,133 shares of common stock. |
| F3 | Such option will become exercisable (subject to the optionholder's continued employment) quarterly in substantially equal installments (any fractional shares to be cumulated and to become exercisable at the end of the earliest succeeding quarterly period in which a whole share equivalent is accumulated) over four years from the date of grant (November 23, 2022). |